The Patent Finder
US

Isoindolinone Inhibitors of the MDM2-P53 Interaction Having Anticancer Activity

US 10,981,898 In force
OverviewFamilyAssignmentsSources & methods

Term ends Sep 29, 2036 · Medium confidence

Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 10,544,132), so the cap could be lower.

Filed Aug 8, 2019 as application 16/535,931 · Granted Apr 20, 2021
Base term, 20 years from filing
Today
20 years from filing
2016 2036
Clock starts
Sep 29, 2016
Term ends
Sep 29, 2036
Granted
Apr 20, 2021
base term fee events Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,526,311, US 10,544,132, US 11,261,171, to Sep 29, 2036. The term already ends on or before that date, so the cap shortened nothing.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Sep 29, 2016, when application PCT/GB2016/053042, the earliest non-provisional in its chain, was filed (this one was filed Aug 8, 2019)Sep 29, 2036High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,526,311, US 10,544,132, US 11,261,171)resolves to Sep 29, 2036, no earlier than this term, so no changeMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderSep 29, 2036Medium confidence

Partial family

Application PCT/GB2016/053042PCT application
no patent term
no patent term
US 10,544,132In force
no later than Sep 2036
no later than Sep 2036
US 10,981,898this patent
Sep 2036
Sep 2036
US 12,071,429In force
Sep 2036
Sep 2036
Application 18/767,400Pending
not computed
not computed
Partial: 1 of the 5 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Aug 9, 2019
Reel 50013, frame 911
Chessari, Gianni; Howard, Steven; Buck, Ildiko Maria; Cons, Benjamin David; Johnson, Christopher Norbert; Holvey, Rhian Sara; Rees, David Charles; St. Denis, Jeffrey David; Tamanini, EmilianoAstex Therapeutics LimitedAssignment of Assignor's Interest
Aug 9, 2019
Reel 50013, frame 930
Osborne, James Daniel; Peach, Joanne; Lewis, Arwel; Hirst, Kim Louise; Whittaker, Benjamin Paul; Watson, David Wyn; Mitchell, Dale RobertBiofocus Dpi LimitedAssignment of Assignor's Interest
Aug 9, 2019
Reel 50013, frame 954
Golding, Bernard Thomas; Hardcastle, Ian Robert; Cano, Celine Florence; Nobel, Martin Edward Mäntylä; Miller, Duncan Charles; University of Newcastle Upon TyneCancer Research Technology LimitedAssignment of Assignor's Interest
Aug 9, 2019
Reel 50014, frame 25
Biofocus Dpi LimitedAstex Therapeutics LimitedAssignment of Assignor's Interest
Aug 9, 2019
Reel 50014, frame 73
Griffin, Roger John; University of Newcastle Upon TyneCancer Research Technology LimitedAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited